Nektar Therapeutics | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
172.47 M |
Public Float |
88.95 M |
Nektar Therapeutics | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.52 |
Market Cap |
$6.13 B |
Shares Outstanding |
174.31 M |
Public Float |
171.2 M |
Address |
455 Mission Bay Boulevard South San Francisco California 94158 United States |
Employees | - |
Website | http://www.nektar.com |
Updated | 07/08/2019 |
Nektar Therapeutics is a clinical-stage biopharmaceutical company, which engages in developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms. It operates through the United States and Europe geogrpahical segments. The company was founded in 1990 and is headquartered in San Francisco, CA. |